Tumor Protein RNF128 Linked to Immune Resistance in Bladder Cancer
A new study links tumor-cell RNF128 to reduced CD8-positive T-cell infiltration and poorer immune checkpoint blockade responses in bladder cancer.
A new study links tumor-cell RNF128 to reduced CD8-positive T-cell infiltration and poorer immune checkpoint blockade responses in bladder cancer.
A new GLOBOCAN 2024-based analysis estimates that bladder cancer cases in Africa will rise 133 percent and deaths 138 percent ...
A new study in Myeloid Cells reports that the vaccine adjuvant AS01 induces trained immunity in human monocytes and slows ...
An updated systematic review of 12 studies in 1,248 patients finds sequential intravesical gemcitabine plus docetaxel offers durable disease control ...
A propensity score–matched retrospective study found that preoperative bladder artery embolization followed by TURBT within 24 hours reduced blood loss, ...
A single case report describes a 73-year-old man with HER2-low metastatic urothelial carcinoma whose liver metastases nearly resolved after treatment ...
A new narrative review finds that the clinical meaning of immune infiltration in bladder cancer depends on cell localization, functional ...
A urine-based DNA methylation marker, TAGMe, was associated with poorer outcomes in urothelial carcinoma and improved preoperative risk prediction in ...
A combined MRI radiomics and clinical nomogram achieved an area under the curve of 0.897 in temporal validation for predicting ...
In a 108-patient tissue study, mismatch repair deficiency was absent from bladder urothelial carcinoma cases and stable across paired specimens, ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine